Literature DB >> 22552093

Cancer biology: The director's cut.

Antonio Gentilella, George Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22552093     DOI： 10.1038/485050a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs.

Authors:  Ryan J O Dowling; Ivan Topisirovic; Tommy Alain; Michael Bidinosti; Bruno D Fonseca; Emmanuel Petroulakis; Xiaoshan Wang; Ola Larsson; Anand Selvaraj; Yi Liu; Sara C Kozma; George Thomas; Nahum Sonenberg
Journal:  Science       Date:  2010-05-28       Impact factor: 47.728

2.  mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.

Authors:  Hala Elnakat Thomas; Carol A Mercer; Larissa S Carnevalli; Jongsun Park; Jesper B Andersen; Elizabeth A Conner; Kazuhiro Tanaka; Tomoo Matsutani; Akio Iwanami; Bruce J Aronow; Liu Manway; S Michel Maira; Snorri S Thorgeirsson; Paul S Mischel; George Thomas; Sara C Kozma
Journal:  Sci Transl Med       Date:  2012-04-25       Impact factor: 17.956

3.  Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.

Authors:  H B Jefferies; S Fumagalli; P B Dennis; C Reinhard; R B Pearson; G Thomas
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

4.  Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells.

Authors:  S Shama; D Avni; R M Frederickson; N Sonenberg; O Meyuhas
Journal:  Gene Expr       Date:  1995

5.  Oligopyrimidine tract at the 5' end of mammalian ribosomal protein mRNAs is required for their translational control.

Authors:  S Levy; D Avni; N Hariharan; R P Perry; O Meyuhas
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 6.  Developmental timing of mRNA translation--integration of distinct regulatory elements.

Authors:  Melanie C MacNicol; Angus M MacNicol
Journal:  Mol Reprod Dev       Date:  2010-08       Impact factor: 2.609

7.  Structure of the human mTOR complex I and its implications for rapamycin inhibition.

Authors:  Calvin K Yip; Kazuyoshi Murata; Thomas Walz; David M Sabatini; Seong A Kang
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

8.  Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.

Authors:  Nicholas T Ingolia; Sina Ghaemmaghami; John R S Newman; Jonathan S Weissman
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

9.  A unifying model for mTORC1-mediated regulation of mRNA translation.

Authors:  Carson C Thoreen; Lynne Chantranupong; Heather R Keys; Tim Wang; Nathanael S Gray; David M Sabatini
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

10.  The translational landscape of mTOR signalling steers cancer initiation and metastasis.

Authors:  Andrew C Hsieh; Yi Liu; Merritt P Edlind; Nicholas T Ingolia; Matthew R Janes; Annie Sher; Evan Y Shi; Craig R Stumpf; Carly Christensen; Michael J Bonham; Shunyou Wang; Pingda Ren; Michael Martin; Katti Jessen; Morris E Feldman; Jonathan S Weissman; Kevan M Shokat; Christian Rommel; Davide Ruggero
Journal:  Nature       Date:  2012-02-22       Impact factor: 69.504
View more
  9 in total

Review 1.  Translational Control during Cellular Senescence.

Authors:  Matthew J Payea; Carlos Anerillas; Ravi Tharakan; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

2.  Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathway.

Authors:  Rosa Martín-Pérez; Carmen Palacios; Rosario Yerbes; Ana Cano-González; Daniel Iglesias-Serret; Joan Gil; Mauricio J Reginato; Abelardo López-Rivas
Journal:  Cancer Res       Date:  2014-01-22       Impact factor: 12.701

Review 3.  A liaison between mTOR signaling, ribosome biogenesis and cancer.

Authors:  Antonio Gentilella; Sara C Kozma; George Thomas
Journal:  Biochim Biophys Acta       Date:  2015-02-28

Review 4.  Regulation of global and specific mRNA translation by the mTOR signaling pathway.

Authors:  Neethi Nandagopal; Philippe P Roux
Journal:  Translation (Austin)       Date:  2015-02-02

Review 5.  Ribosome biogenesis in cancer: new players and therapeutic avenues.

Authors:  Joffrey Pelletier; George Thomas; Siniša Volarević
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

6.  Autogenous Control of 5′TOP mRNA Stability by 40S Ribosomes.

Authors:  Antonio Gentilella; Francisco D Morón-Duran; Pedro Fuentes; Guilherme Zweig-Rocha; Ferran Riaño-Canalias; Joffrey Pelletier; Marta Ruiz; Gemma Turón; Julio Castaño; Albert Tauler; Clara Bueno; Pablo Menéndez; Sara C Kozma; George Thomas
Journal:  Mol Cell       Date:  2017-06-29       Impact factor: 17.970

7.  Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation.

Authors:  Joseph Tcherkezian; Marie Cargnello; Yves Romeo; Edward L Huttlin; Genevieve Lavoie; Steven P Gygi; Philippe P Roux
Journal:  Genes Dev       Date:  2014-02-15       Impact factor: 11.361

Review 8.  Ribosome profiling: a Hi-Def monitor for protein synthesis at the genome-wide scale.

Authors:  Audrey M Michel; Pavel V Baranov
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-05-20       Impact factor: 9.957

9.  Controversies around the function of LARP1.

Authors:  Andrea J Berman; Carson C Thoreen; Zinaida Dedeic; James Chettle; Philippe P Roux; Sarah P Blagden
Journal:  RNA Biol       Date:  2020-04-01       Impact factor: 4.652
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.